Harmony Biosciences(HRMY) - 2025 Q4 - Earnings Call Transcript

Harmony Biosciences (NasdaqGM:HRMY) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsAdam Zaeske - EVP and Chief Commercial OfficerJeffrey M. Dayno - President and CEOKumar Budur - Chief Medical and Scientific OfficerMatthew Beck - Investor RelationsPatrick Trucchio - Managing Director of Equity ResearchPoorna Kannan - Biotech Equity Research AssociateSandip Kapadia - CFO and Chief Administrative OfficerConference Call ParticipantsBhavin Patel - AnalystCorinne Johnson - AnalystDavid A ...